S-09 Endodontic Implications of Medication-related Osteonecrosis of the Jaw: Practical Considerations & Clinical Pearls
CE Hours: 1.0
Description: Medication-related osteonecrosis of the Jaw (MRONJ) is a serious side effect of bone-modifying agents, such as bisphosphonates, denosumab, and antiangiogenic drugs. Persistent disease following root canal treatment and surgical endodontic therapy may increase the risk for MRONJ. In this session, we will discuss practical approaches to recognize risk factors, risk mitigation strategies, and MRONJ management for patients requiring surgical and non-surgical endodontic therapy.
Learning Objectives:
- Identify risk factors for MRONJ.
- Identify methods to reduce the risk of MRONJ.
- Describe the assessment and management of MRONJ.
Key:
David K. Lam, MD, DDS, PHD
David K. Lam, MD, DDS, PhD, FRCDC, FACS serves as the Associate Dean for Medical Integration, Dr. T. Galt and Lee DeHaven Atwood Endowed Professor, and Chair of the Department of Oral and Maxillofacial Surgery at the University of the Pacific. Dr. Lam specializes in the comprehensive surgical management of patients with cancer, pathology, and trigeminal nerve injury. His research and clinical programs are closely integrated, and his research addresses the challenges he faces in the clinical management of oral and maxillofacial surgery patients. He obtained his DDS with Honors from the University of Toronto and subsequently obtained a PhD in the Collaborative Program in Neuroscience and Oral & Maxillofacial Surgery Specialty Certificate from the same institution. He earned his MD from the University of California, Davis and completed a Postdoctoral Neuroscience Research Fellowship, as well as a Surgical Fellowship in Maxillofacial Oncology and Reconstructive Surgery at the University of California, San Francisco. He is a Diplomate of the American Board of Oral & Maxillofacial Surgery, Fellow of the American College of Surgeons, and Fellow (OMFS) in the Royal College of Dentists in Canada. His funded research focuses on the diagnosis and management of pathology, nerve injury, and pain. In addition to funding on research, education and training grants, Lam has published and presented internationally, nationally and locally on a variety of topics relevant to his research and clinical interests.
Disclosure(s): No financial relationships to disclose